Optimizing Investigator Fees

ISR’s reports have been featured in numerous industry publications and news sources over the years. Below is a link to Appliedclinicaltrialsonline.com’s:

“Optimizing Investigator Fees”

https://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Data+Analysis/Optimizing-Investigator-Fees/ArticleStandard/Article/detail/800011

I’m not sure if it’s just me, but we still have some work to do on the automatically generated e-mails. I’ve provided DETAILED and SPECIFIC instructions I’d like to see implemented.

Kelly and Brian – please work together to fulfill these requests. If something is not possible, I’d like to hear recommendations on an alternative option to accomplish the intended goal.

1.       Update all e-mail subject lines to something intuitive and reasonable for the purpose of the e-mail:  Currently a user is getting an e-mail with the subject line “

ISR’s report provides the pharmaceutical industry and its service providers with novel peer-based guidance on the adoption, use, and outsourcing of risk-based clinical monitoring models.

Your order has been processed

ISR’s reports have been featured in numerous industry publications and news sources over the years. Below is a link to Appliedclinicaltrialsonline.com’s:

“What Does the Future Hold for Clinical Monitoring?”

https://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/article/articleDetail.jsp?id=810203